Informationskortet til patienten bør omfatte følgende information: • At Thelin er teratogent. • At kvinder i den fødedygtige alder skal bruge sikker prævention, og at de skal informere deres læge om mulig graviditet, før udskrivning af en ny recept. • Nødvendigheden af at kvindelige patienter kontakter deres behandlingslæge, straks efter at de får mistanke om, at de er gravide. • At Thelin er levertoksisk, og at de er nødt til at møde op til regelmæssig blodprøvetagning. • Nødvendigheden af at fortælle deres læge om alle uønskede hændelser. • Nødvendigheden af at fortælle deres læge, at de tager Thelin.
The Patient information card should include the following information • That Thelin is teratogenic • The need to ensure that women of child bearing age are using effective contraception and that patients should inform their doctors of any possibility of pregnancy before a new prescription is issued • The need for female patients to contact their treating doctor immediately if they suspect that they might be pregnant. • That Thelin is hepatotoxic and they will need to attend for regular blood tests • The need to tell their doctor about any adverse events • The need to tell their doctor that they are taking Thelin